These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 24033263

  • 1. Adherence and assured administration of medications in bipolar patients.
    El-Mallakh PL, El-Mallakh RS.
    Curr Drug Deliv; 2013 Dec; 10(6):706-12. PubMed ID: 24033263
    [Abstract] [Full Text] [Related]

  • 2. Medication adherence and the use of long-acting antipsychotics in bipolar disorder.
    El-Mallakh RS.
    J Psychiatr Pract; 2007 Mar; 13(2):79-85. PubMed ID: 17414683
    [Abstract] [Full Text] [Related]

  • 3. What is the evidence for the use of second-generation antipsychotic long-acting injectables as maintenance treatment in bipolar disorder?
    Samalin L, Nourry A, Charpeaud T, Llorca PM.
    Nord J Psychiatry; 2014 May; 68(4):227-35. PubMed ID: 23795859
    [Abstract] [Full Text] [Related]

  • 4. Long-Acting Injectable Second-Generation/Atypical Antipsychotics for the Management of Bipolar Disorder: A Systematic Review.
    Keramatian K, Chakrabarty T, Yatham LN.
    CNS Drugs; 2019 May; 33(5):431-456. PubMed ID: 30963507
    [Abstract] [Full Text] [Related]

  • 5. [French Society for Biological Psychiatry and Neuropsychopharmacology task force: Formal Consensus for the prescription of depot antipsychotics].
    Samalin L, Abbar M, Courtet P, Guillaume S, Lancrenon S, Llorca PM.
    Encephale; 2013 Dec; 39 Suppl 4():189-203. PubMed ID: 24373464
    [Abstract] [Full Text] [Related]

  • 6. Long-acting injectable antipsychotics for the maintenance treatment of bipolar disorder.
    Gigante AD, Lafer B, Yatham LN.
    CNS Drugs; 2012 May 01; 26(5):403-20. PubMed ID: 22494448
    [Abstract] [Full Text] [Related]

  • 7. Medication adherence and discontinuation of long-acting injectable versus oral antipsychotics in patients with schizophrenia or bipolar disorder.
    Greene M, Yan T, Chang E, Hartry A, Touya M, Broder MS.
    J Med Econ; 2018 Feb 01; 21(2):127-134. PubMed ID: 28895758
    [Abstract] [Full Text] [Related]

  • 8. Identifying Profiles of Patients With Bipolar I Disorder Who Would Benefit From Maintenance Therapy With a Long-Acting Injectable Antipsychotic.
    Tohen M, Goldberg JF, Hassoun Y, Sureddi S.
    J Clin Psychiatry; 2020 Jun 16; 81(4):. PubMed ID: 32558403
    [Abstract] [Full Text] [Related]

  • 9. Depot antipsychotic medications in bipolar disorder: a review of the literature.
    Bond DJ, Pratoomsri W, Yatham LN.
    Acta Psychiatr Scand Suppl; 2007 Jun 16; (434):3-16. PubMed ID: 17688458
    [Abstract] [Full Text] [Related]

  • 10. Long-acting injectable antipsychotics as maintenance treatments for bipolar disorder-A critical review of the evidence.
    Boyce P, Irwin L, Morris G, Hamilton A, Mulder R, Malhi GS, Porter RJ.
    Bipolar Disord; 2018 Nov 16; 20 Suppl 2():25-36. PubMed ID: 30328222
    [Abstract] [Full Text] [Related]

  • 11. Antipsychotic medications in the treatment of bipolar disorder.
    Surja AA, Tamas RL, El-Mallakh RS.
    Curr Drug Targets; 2006 Sep 16; 7(9):1217-24. PubMed ID: 17017897
    [Abstract] [Full Text] [Related]

  • 12. Long-acting injectable antipsychotics in the treatment of schizophrenia: their role in relapse prevention.
    Agid O, Foussias G, Remington G.
    Expert Opin Pharmacother; 2010 Oct 16; 11(14):2301-17. PubMed ID: 20586707
    [Abstract] [Full Text] [Related]

  • 13. A prospective 4-year naturalistic follow-up of treatment and outcome of 300 bipolar I and II patients.
    Simhandl C, König B, Amann BL.
    J Clin Psychiatry; 2014 Mar 16; 75(3):254-62; quiz 263. PubMed ID: 24717379
    [Abstract] [Full Text] [Related]

  • 14. Adherence to depot versus oral antipsychotic medication in schizophrenic patients during the long-term therapy.
    Stanković Z, Ille T.
    Vojnosanit Pregl; 2013 Mar 16; 70(3):267-73. PubMed ID: 23607237
    [Abstract] [Full Text] [Related]

  • 15. Treatment adherence with antipsychotic medications in bipolar disorder.
    Sajatovic M, Valenstein M, Blow FC, Ganoczy D, Ignacio RV.
    Bipolar Disord; 2006 Jun 16; 8(3):232-41. PubMed ID: 16696824
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Risperidone long-acting injectable (Risperdal Consta®) for maintenance treatment in patients with bipolar disorder.
    Bobo WV, Shelton RC.
    Expert Rev Neurother; 2010 Nov 16; 10(11):1637-58. PubMed ID: 20977322
    [Abstract] [Full Text] [Related]

  • 20. Medication Adherence and Discontinuation of Aripiprazole Once-Monthly 400 mg (AOM 400) Versus Oral Antipsychotics in Patients with Schizophrenia or Bipolar I Disorder: A Real-World Study Using US Claims Data.
    Yan T, Greene M, Chang E, Hartry A, Touya M, Broder MS.
    Adv Ther; 2018 Oct 16; 35(10):1612-1625. PubMed ID: 30206822
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.